摘要
根据本院药物临床试验机构实际质量控制管理经验,初步探讨了临床研究协调员(CRC)参与的基于风险的闭环式质控模式。基于风险的质控模式增加了质控效率,闭环式质控使得质控真正能发挥作用, CRC的引入充实了质控团队。该质控模式为药物临床试验机构的质控提供了一种新的途径。
Based on the actual management experience on quality control of drug clinical trial institutions in our hospital,a risk-based closed-loop quality control model with the participation of clinical research coordinator(CRC) was preliminarily discussed in this paper.The risk-based quality control mode increased the efficiency of quality control,the closed-loop quality control made quality control really work,and the introduction of CRC enriched the quality control team.This quality control model provides a new way for the quality control of drug clinical trial institutions.
作者
谢振伟
范华莹
王瓅珏
吴明凤
郭丹杰
张华
王豪
XIE Zhen-wei;FAN Hua-ying;WANG Li-jue;WU Ming-feng;GUO Dan-jie;ZHANG Hua;WANG Hao(Department of Clinical Trial Institution,Peking University People's Hospital,BEIJING 100044,China)
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2019年第2期90-92,共3页
Chinese Journal of New Drugs and Clinical Remedies
关键词
临床试验
质量控制
风险
临床研究协调员
clinical trial
quality control
risk
clinical research coordinator